CDTX
Price
$48.03
Change
-$1.30 (-2.64%)
Updated
Jun 26 closing price
Capitalization
1B
WINT
Price
$0.37
Change
-$0.00 (-0.00%)
Updated
Jun 26 closing price
Capitalization
1.67M
Interact to see
Advertisement

CDTX vs WINT

Header iconCDTX vs WINT Comparison
Open Charts CDTX vs WINTBanner chart's image
Cidara Therapeutics
Price$48.03
Change-$1.30 (-2.64%)
Volume$1.94M
Capitalization1B
Windtree Therapeutics
Price$0.37
Change-$0.00 (-0.00%)
Volume$1.29M
Capitalization1.67M
CDTX vs WINT Comparison Chart in %
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. WINT commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Hold and WINT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (CDTX: $48.03 vs. WINT: $0.46)
Brand notoriety: CDTX and WINT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 373% vs. WINT: 211%
Market capitalization -- CDTX: $1B vs. WINT: $1.67M
CDTX [@Biotechnology] is valued at $1B. WINT’s [@Biotechnology] market capitalization is $1.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileWINT’s FA Score has 1 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • WINT’s FA Score: 1 green, 4 red.
According to our system of comparison, WINT is a better buy in the long-term than CDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 5 TA indicator(s) are bullish while WINT’s TA Score has 4 bullish TA indicator(s).

  • CDTX’s TA Score: 5 bullish, 4 bearish.
  • WINT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CDTX is a better buy in the short-term than WINT.

Price Growth

CDTX (@Biotechnology) experienced а +125.39% price change this week, while WINT (@Biotechnology) price change was -17.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.61%. For the same industry, the average monthly price growth was +38.86%, and the average quarterly price growth was +17.21%.

Reported Earning Dates

CDTX is expected to report earnings on May 08, 2025.

WINT is expected to report earnings on Apr 15, 2025.

Industries' Descriptions

@Biotechnology (+9.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($1.01B) has a higher market cap than WINT($1.67M). CDTX YTD gains are higher at: 78.683 vs. WINT (-97.389). WINT has higher annual earnings (EBITDA): -15.85M vs. CDTX (-192.6M). CDTX has more cash in the bank: 168M vs. WINT (1.17M). WINT has less debt than CDTX: WINT (1.58M) vs CDTX (2.67M). CDTX has higher revenues than WINT: CDTX (302K) vs WINT (0).
CDTXWINTCDTX / WINT
Capitalization1.01B1.67M60,180%
EBITDA-192.6M-15.85M1,215%
Gain YTD78.683-97.389-81%
P/E RatioN/A0.83-
Revenue302K0-
Total Cash168M1.17M14,322%
Total Debt2.67M1.58M169%
FUNDAMENTALS RATINGS
CDTX vs WINT: Fundamental Ratings
CDTX
WINT
OUTLOOK RATING
1..100
8791
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3498
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WINT's Valuation (56) in the Biotechnology industry is in the same range as CDTX (86). This means that WINT’s stock grew similarly to CDTX’s over the last 12 months.

WINT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CDTX (100). This means that WINT’s stock grew similarly to CDTX’s over the last 12 months.

WINT's SMR Rating (99) in the Biotechnology industry is in the same range as CDTX (100). This means that WINT’s stock grew similarly to CDTX’s over the last 12 months.

CDTX's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for WINT (98). This means that CDTX’s stock grew somewhat faster than WINT’s over the last 12 months.

WINT's P/E Growth Rating (6) in the Biotechnology industry is significantly better than the same rating for CDTX (100). This means that WINT’s stock grew significantly faster than CDTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXWINT
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend about 1 month ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 5 days ago
86%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECTMX16.54N/A
N/A
Eaton Vance Dividend Builder C
SETAX16.01N/A
N/A
SEI Real Estate F (SIMT)
MVGMX17.94N/A
N/A
MFS Low Volatility Global Equity R4
PDARX11.69N/A
N/A
Principal Diversified Real Asset R6
VEVCX43.28N/A
N/A
Victory Sycamore Established Value C

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-2.64%
BPTSY - CDTX
92%
Closely correlated
N/A
UNCY - CDTX
51%
Loosely correlated
-4.35%
INDP - CDTX
40%
Loosely correlated
+24.76%
REPL - CDTX
39%
Loosely correlated
+0.11%
IVVD - CDTX
36%
Loosely correlated
+13.43%
More

WINT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WINT has been loosely correlated with MLEC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if WINT jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WINT
1D Price
Change %
WINT100%
+23.24%
MLEC - WINT
49%
Loosely correlated
+6.60%
DVHGF - WINT
37%
Loosely correlated
N/A
INMB - WINT
31%
Poorly correlated
-14.79%
CDTX - WINT
27%
Poorly correlated
-2.64%
VRAX - WINT
27%
Poorly correlated
+1.32%
More